Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3OTHER_GOV 2NIH 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gastrointestinal 58Genitourinary 17Thoracic 16Lymphoid 16Gynecologic 16Head & Neck 14Breast 12Other hematologic neoplasm 11CNS 8Sarcoma 7Tumor-Agnostic 6Dermatologic 6Plasma cell 5Myeloid 5Other solid neoplasm 3Other 3Endocrine 3Classical hematology 3Other neoplasm 2

Conditions

Insulinoma 1Hyperaldosteronism 1Carcinoma, Neuroendocrine 1Adrenocortical Carcinoma 1

Interventions

lutetium Lu 177 dotatate 36Everolimus 32pembrolizumab 24Temozolomide 21Magnetic Resonance Spectroscopy 21Nivolumab 18lenvatinib 17gallium Ga 68 dotatate 16cabozantinib 15Cisplatin 15lanreotide 143-Iodobenzylguanidine 14Capecitabine 13trametinib 12dabrafenib 12Bevacizumab 12Octreotide 11Surveys and Questionnaires 10Surgical Procedures, Operative 10Sunitinib 10Radiosurgery 10Positron Emission Tomography Computed Tomography 10Blood Specimen Collection 10Sorafenib 9Paclitaxel 9Ipilimumab 9Carboplatin 9surufatinib 8Etoposide 8Doxorubicin 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Observation × Endocrine × Clear all
NCT07272187 2025-12-09

EURAGIL

Herlev Hospital

Recruiting
138 enrolled
Endocrine

Hyperaldosteronism, Insulinoma

NCT07192991 2025-09-25

NECTARINE

Latin American Cooperative Oncology Group

Not yet recruiting
200 enrolled
Endocrine

Carcinoma, Neuroendocrine

NCT03723941 2024-08-01

ACACIA

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase 3 Completed
40 enrolled
Endocrine

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡